Abiopharma

New Form SCHEDULE 13G/A - CytomX Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001214659-25-007872 Size: 29 KB

New Form SCHEDULE 13G/A - ALX ONCOLOGY HOLDINGS INC Filed: 2025-05-15 AccNo: 0001214659-25-007868 Size: 29 KB

New Form SCHEDULE 13G/A - REVIVA PHARMACEUTICALS HOLDINGS, INC. Filed: 2025-05-15 AccNo: 0001214659-25-007880 Size: 32 KB

New Form SCHEDULE 13G/A - Compass Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001214659-25-007870 Size: 14 KB

Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Gilead - Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer at 2025 ASCO and EHA

New Form SCHEDULE 13G - Tyra Biosciences, Inc. Filed: 2025-05-15 AccNo: 0000902664-25-002398 Size: 15 KB

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025

New Form SCHEDULE 13G - Dianthus Therapeutics, Inc. /DE/ Filed: 2025-05-15 AccNo: 0000902664-25-002397 Size: 15 KB

Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer at 2025 ASCO and EHA

New Form SCHEDULE 13G - COMMUNITY HEALTH SYSTEMS INC Filed: 2025-05-15 AccNo: 0001104659-25-049443 Size: 122 KB

New Form 8-K for Quantum-Si Incorporated

New Form SCHEDULE 13G/A - Marker Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001140361-25-019283 Size: 7 KB

New Form SCHEDULE 13G - TANDEM DIABETES CARE INC Filed: 2025-05-15 AccNo: 0001398344-25-009644 Size: 13 KB

Agilent Technologies, Inc. - Agilent to Participate in Jefferies Global Healthcare Conference